TRCT
DVAX

Tower Research Capital (TRC)’s Dynavax Technologies DVAX Stock Holding History

Tower Research Capital (TRC)’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-927
Closed -$14.3K – 5210
2025
Q4 		$14.3K Sell
927
-2,965
-76% -$32.7K ﹤0.01% 3361
2025
Q3 		$38.6K Sell
3,892
-12,347
-76% -$129K ﹤0.01% 2729
2025
Q2 		$161K Buy
16,239
+12,371
+320% +$130K ﹤0.01% 1985
2025
Q1 		$50.2K Sell
3,868
-14,971
-79% -$198K ﹤0.01% 2234
2024
Q4 		$241K Buy
18,839
+1,966
+12% +$23.8K ﹤0.01% 1590
2024
Q3 		$188K Sell
16,873
-35,476
-68% -$391K 0.01% 1682
2024
Q2 		$588K Buy
52,349
+38,822
+287% +$452K 0.01% 1203
2024
Q1 		$168K Buy
13,527
+7,769
+135% +$101K ﹤0.01% 1523
2023
Q4 		$80.5K Buy
5,758
+98
+2% +$1.36K ﹤0.01% 2796
2023
Q3 		$83.6K Sell
5,660
-5,017
-47% -$70.6K ﹤0.01% 2114
2023
Q2 		$138K Buy
10,677
+4,867
+84% +$55.5K ﹤0.01% 1818
2023
Q1 		$57K Sell
5,810
-7,394
-56% -$78.9K ﹤0.01% 2376
2022
Q4 		$141K Sell
13,204
-1,531
-10% -$17.8K 0.01% 1562
2022
Q3 		$154K Sell
14,735
-6,847
-32% -$89.2K ﹤0.01% 2170
2022
Q2 		$272K Sell
21,582
-11,934
-36% -$127K 0.01% 1547
2022
Q1 		$363K Buy
33,516
+4,407
+15% +$53.5K ﹤0.01% 1348
2021
Q4 		$410K Sell
29,109
-25,334
-47% -$417K 0.01% 1246
2021
Q3 		$1.05M Buy
54,443
+47,430
+676% +$630K 0.03% 508
2021
Q2 		$69K Sell
7,013
-15,310
-69% -$139K ﹤0.01% 2747
2021
Q1 		$220K Sell
22,323
-19,597
-47% -$162K ﹤0.01% 1926
2020
Q4 		$186K Buy
41,920
+7,963
+23% +$36K 0.01% 1765
2020
Q3 		$147K Buy
33,957
+11,364
+50% +$81.1K ﹤0.01% 2835
2020
Q2 		$200K Buy
+22,593
New +$114K 0.01% 1783
2020
Q1 		– Sell
-3,380
Closed -$19K – 3217
2019
Q4 		$19K Buy
+3,380
New +$18.1K ﹤0.01% 1945
2019
Q2 		– Sell
-487
Closed -$4K – 3815
2019
Q1 		$4K Buy
+487
New +$4.76K ﹤0.01% 3153
2018
Q4 		– Sell
-145
Closed -$2K – 3912
2018
Q3 		$2K Sell
145
-3,266
-96% -$44.2K ﹤0.01% 3422
2018
Q2 		$52K Buy
+3,411
New +$59K ﹤0.01% 1831
2018
Q1 		– Sell
-1,049
Closed -$20K – 3373
2017
Q4 		$20K Sell
1,049
-2,138
-67% -$42.9K ﹤0.01% 2059
2017
Q3 		$68K Buy
3,187
+1,109
+53% +$17.5K 0.01% 1703
2017
Q2 		$20K Buy
2,078
+398
+24% +$2.58K ﹤0.01% 1213
2017
Q1 		$10K Buy
1,680
+980
+140% +$4.71K ﹤0.01% 1761
2016
Q4 		$3K Buy
+700
New +$5.13K ﹤0.01% 3237
2016
Q2 		– Sell
-1,161
Closed -$22K – 4519
2016
Q1 		$22K Buy
1,161
+910
+363% +$18.4K ﹤0.01% 1269
2015
Q4 		$6K Buy
251
+174
+226% +$4.36K ﹤0.01% 2747
2015
Q3 		$2K Sell
77
-1,501
-95% -$42.5K ﹤0.01% 3320
2015
Q2 		$37K Sell
1,578
-5,209
-77% -$113K ﹤0.01% 1589
2015
Q1 		$153K Buy
6,787
+5,522
+437% +$106K 0.02% 572
2014
Q4 		$21K Sell
1,265
-9,334
-88% -$142K ﹤0.01% 1557
2014
Q3 		$152K Buy
+10,599
New +$153K 0.02% 650
2014
Q1 		– Sell
-30
Closed -$1K – 4541
2013
Q4 		$1K Buy
+30
New +$439 ﹤0.01% 4192

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tower Research Capital (TRC)'s DVAX Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 927 shares — an estimated $14.3K sold.

Tower Research Capital (TRC) first reported a position in DVAX in Q4 2013 and held it in 40 quarters. The position peaked at $1.05M in Q3 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 927 Dynavax Technologies shares in Q1 2026, an estimated $14.3K.
  • Tower Research Capital (TRC) first reported a position in Dynavax Technologies in Q4 2013 and held it in 40 quarters.
  • Tower Research Capital (TRC)'s Dynavax Technologies position peaked at $1.05M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.